ICLR

TentativeAI MemoPost-earnings T+1

ICON

As of 2026-10-21/Post-earnings T+1/Confidence low

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-21 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Report quality notice

peer set is too generic or lacks enough direct operating comparators

Action

—

Confidence

low

Horizon

—

Key catalyst

Q3 results are scheduled for October 27, not October 20 • 2026-10-27

Base target: $180 / p=50% prob

Biggest risk

Q2 adjusted EBITDA was down 21.7% year over year, and management flagged variability in second-half pass-through activity. ICON's 2025 annual filing also reported material weaknesses in financial-reporting controls. No Q3 result or post-print analyst revision is available as of this report. [#PR-2026-07-29] ICON Q2 results [#IR-20F-2026-05-27] ICON Form 20-F

Invalidation

Break below $140 or thesis failure.

What would change my mind?

Q2's $3.12 billion of net wins and $23.4 billion backlog could support recovery if direct-fee work converts profitably; ICON reaffirmed 2026 revenue guidance of $7.85–8.15 billion and adjusted EPS guidance of $10.00–11.00. This remains a test, not a confirmed Q3 improvement. [#PR-2026-07-29] ICON Q2 results

Research note

Recommendation

—

Confidence

low

As of

2026-10-21

Base target

$180

p=50%

Bull target

$205

p=25%

Bear target

$140

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Bookings-to-revenue and margin conversion
Q2's $3.12 billion of net wins and $23.4 billion backlog could support recovery if direct-fee work converts profitably; ICON reaffirmed 2026 revenue guidance of $7.85–8.15 billion and adjusted EPS guidance of $10.00–11.00.
This remains a test, not a confirmed Q3 improvement.

BearKey bullets

Financial-reporting control remediation and related costs remain risks following material weaknesses reported for 2025.
[#IR-20F-2026-05-27] ICON Form 20-F
ICON priced $2.15 billion of unsecured notes in August for intended debt refinancing; debt-service and capital-allocation flexibility warrant monitoring.

WatchKey bullets

Q3 results are scheduled for October 27, not October 20

Summary

High-level snapshot

Recommendation

Model confidence

low

Timeframe

Asset

Equity

Trigger

Post-earnings T+1

Base case: $180 (p=50%)

Target spread vs base: +14% / -22%

Scenario probabilities

Bull Target: $205 (p=25%)Base Target: $180 (p=50%)Bear Target: $140 (p=25%)

Commentary

Neutral, low-conviction monitoring view. ICON has not yet released Q3 results, so an earnings surprise, post-release price reaction and post-print analyst revisions are unavailable—not positive signals. The supplied $174.19 price is an October 20 anchor, not a post-earnings reaction. Deterministic evidence quality is low (0.24) and uncertainty high (0.793), despite the scheduled event's high novelty score.

As of 2026-10-21 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Bookings-to-revenue and margin conversion

Scenarios

Bull Target (Scenario probability)

$205 / p=25% prob

Base Target (Scenario probability)

$180 / p=50% prob

Bear Target (Scenario probability)

$140 / p=25% prob

Analysis 2026-10-21 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-10-27
Q3 results are scheduled for October 27, not October 20
ICON scheduled its Q3 2026 release for after the October 27 close and its call for October 28. The October 20 post-earnings trigger is premature; no Q3 surprise, guidance revision or post-print reaction can yet be assessed. The release should test bookings quality, backlog conversion, margins and 2026 guidance. [#PR-EARNINGS-2026-10-08] ICON announcement
Prob 100.00% • Move 0.00% • Priced-in 50.00%

Short-term Catalysts

Next few weeks

No short-term catalysts

Long-term Catalysts

Months to a year

Bookings-to-revenue and margin conversion
2026-12-31
Q2 net business wins were $3.12 billion and closing backlog was $23.4 billion, but adjusted EBITDA fell 21.7% year over year. Subsequent results must show whether direct-fee wins translate into revenue and margin recovery rather than mainly pass-through activity. [#PR-2026-07-29] ICON Q2 results
Prob 50% • Move 7% • Priced-in 30%

Risks

Financial-reporting control remediation and related costs remain risks following material weaknesses reported for 2025. [#IR-20F-2026-05-27] ICON Form 20-F
ICON priced $2.15 billion of unsecured notes in August for intended debt refinancing; debt-service and capital-allocation flexibility warrant monitoring. [#IR-2026-08-06] ICON notes announcement
Q2 adjusted EBITDA declined 21.7% year over year despite stronger net wins; pass-through activity may obscure direct-fee momentum. [#PR-2026-07-29] ICON Q2 results
The scheduled-run date conflicts with ICON's confirmed October 27 Q3 release date; treating this as a completed earnings print would misstate the evidence. [#PR-EARNINGS-2026-10-08] ICON announcement

Peers

Symbol	Summary
IQV	Direct CRO comparator: IQVIA named ICON among its larger competitors in a February 2026 SEC filing. The relationship is competitive, not a quantified customer or supplier exposure. [#REL-fdbe0da9-f1e1-4940-8062-c19d425c9a88] IQVIA filing

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-21

Loading AI feed…

Symbol

Summary

IQV

Direct CRO comparator: IQVIA named ICON among its larger competitors in a February 2026 SEC filing. The relationship is competitive, not a quantified customer or supplier exposure. [#REL-fdbe0da9-f1e1-4940-8062-c19d425c9a88] IQVIA filing